Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Rotavirus VP4 spike protein is a critical structural component of the rotavirus virion, specifically the RIX4414 strain used in live-attenuated vaccines. It functions as the viral attachment protein, forming 60 dimeric spikes that project from the outer capsid to mediate host cell recognition and entry [1: UniProt P12473]. For the virus to become infectious, VP4 must be proteolytically cleaved by trypsin-like enzymes into two subunits, VP8* and VP5*, which facilitate binding to cell surface receptors and subsequent membrane penetration [2: PubMed 22554309]. In the RIX4414 strain, which is a human G1P isolate, the VP4 protein is the primary determinant of the P-genotype and a major target for neutralizing antibodies [3: WHO Position Paper]. The therapeutic relevance of this protein lies in its role as a vaccine antigen; the Rotarix vaccine (RIX4414) utilizes this protein to elicit a protective immune response, primarily through the production of IgA antibodies that block viral attachment to intestinal enterocytes [4: PubMed 17484215]. Consequently, it is central to preventing severe rotavirus-induced gastroenteritis, a leading cause of childhood diarrhea worldwide [5: GSK Rotarix Prescribing Information].
Induction of neutralizing antibodies (primarily IgA) that bind to the VP4 spikes, preventing viral attachment and entry into host enterocytes.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus VP4 spike protein (RIX4414 strain) (VP4).